Daniel Rea

Publications

  1. Published

    The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

    Daniel Rea, , , , , , , , , , , , , & , 1 Jun 2017, In: The Breast. 33, p. 191-199 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Published

    Role of Tyrosine Kinase Inhibitors in Lung Cancer

    Daniel Palmer, Daniel Rea & Syed Hussain, 1 Jun 2009, In: Anti-Cancer Agents in Medicinal Chemistry. 9, 5, p. 569-575 7 p.

    Research output: Contribution to journalArticle

  3. Published

    Chemotherapy for advanced colorectal cancer

    Daniel Rea, 1 Jan 2003, In: Colonews. 1, p. 3-6 4 p.

    Research output: Contribution to journalArticle

  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published

    Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial

    Daniel Rea & 2 others, & , 1 Feb 2013, In: Clinical Oncology. 25, 2, p. 109-116 8 p.

    Research output: Contribution to journalArticlepeer-review

  10. E-pub ahead of print

    Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study

    Daniel Rea, Dec 2021, In: Breast Cancer. 7, 1, 13 p., 90.

    Research output: Contribution to journalArticlepeer-review

  11. Published
  12. Published
  13. Published

    Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

    Daniel Rea, 29 Oct 2013, In: British Journal of Cancer. 109, 9, p. 2453-2461 9 p.

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. Published
  16. Published
  17. Published
  18. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, , & , 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journalArticlepeer-review

  19. Published
  20. Published

    Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

    Toon Brookes, , , , , , , Daniel Rea, & , 2017, In: Breast Cancer. 3, p. 3

    Research output: Contribution to journalArticlepeer-review

  21. Published

    Metastatic breast cancer response after exemestane withdrawal: A case report

    Daniel Rea, 1 Jan 2004, In: The Breast. 13, p. 66-68 3 p.

    Research output: Contribution to journalArticle

  22. Published

    Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer

    Daniel Rea, , , , , , , , , , , , & , 6 Oct 2003, In: British Journal of Cancer. 89, 7, p. 1155-1158 4 p.

    Research output: Contribution to journalArticle

  23. Published

    Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013

    Daniel Rea, & , 1 Oct 2016, In: Cancer Epidemiology. 44, p. 186-194 9 p.

    Research output: Contribution to journalArticlepeer-review

  24. E-pub ahead of print

    Valuing preferences for treating screen detected ductal carcinoma in situ

    Hannah Bromley, , , , Daniel Rea & Tracy Roberts, 2 Nov 2019, (E-pub ahead of print) In: European Journal of Cancer. 123, p. 130-137 8 p.

    Research output: Contribution to journalArticlepeer-review

  25. Published
  26. Published

    Coagulopathic complications in breast cancer

    Paul Stonelake, Daniel Rea & Gregory Lip, 15 Oct 2003, In: Cancer. 98, p. 1578-1586 9 p.

    Research output: Contribution to journalArticle

  27. Published
  28. Published

    The Breast Cancer Trainees Research Collaborative Group: A New Multidisciplinary Network to Facilitate Breast Cancer Research

    Daniel Rea & , Jan 2020, In: Clinical Oncology. 32, 1, p. e16-e18 3 p.

    Research output: Contribution to journalEditorialpeer-review

  29. Published
  30. Published

    Perspectives on the future of bisphosphonate use in breast cancer patients

    Daniel Rea, 1 Jan 2004, In: Seminars in Oncology. 31, p. 87-91 5 p.

    Research output: Contribution to journalArticle

  31. Published
  32. Published

    Antibacterial prophylaxis after chemotherapy for solid tumours and lymphomas

    Neil Steven, Lucinda Billingham, , , , , Daniel Rea, , , & , 8 Sep 2005, In: New England Journal of Medicine. 353, 10, p. 988-998 11 p.

    Research output: Contribution to journalArticle

  33. Published
  34. E-pub ahead of print

    Adjuvant tamoxifen and exemestane in postmenopausal early breast cancer: ten-year analysis of the randomised phase III TEAM trial

    Daniel Rea, , , , , & , 18 Jul 2017, (E-pub ahead of print) In: The Lancet Oncology.

    Research output: Contribution to journalArticlepeer-review

  35. Published

    Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

    Daniel Rea, , , , , & , 1 Aug 2018, In: European Journal of Cancer . 99, p. 1-8 8 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published
  37. Published
  38. Published
  39. E-pub ahead of print

    Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

    Daniel Rea, , , , , , , , , , , , & , 25 Jul 2020, (E-pub ahead of print) In: Clinical Oncology.

    Research output: Contribution to journalArticlepeer-review

  40. Published
  41. Published
  42. E-pub ahead of print
  43. Published

    Low grade Ductal Carcinoma in situ (DCIS): how best to describe it?

    Daniel Rea, 1 Oct 2014, In: The Breast. 23, 5, p. 693-696 4 p.

    Research output: Contribution to journalArticlepeer-review

  44. Published
  45. Published

    Reply to K.I. Pritchard

    Daniel Rea, & , 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.

    Research output: Contribution to journalArticlepeer-review

  46. Published
  47. Published

    Addressing overtreatment of screen detected DCIS; the LORIS trial

    Toon Brookes, Tracy Roberts, Sarah Pirrie, Lucinda Billingham & 2 others, Sarah Bowden & Daniel Rea, Nov 2015, In: European Journal of Cancer. 51, 16, p. 2296-2303 8 p.

    Research output: Contribution to journalArticlepeer-review

  48. Published

    Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right

    Daniel Rea, , , , , , & , 1 Jul 2016, In: European Journal of Surgical Oncology. 42, 7, p. 994-998 5 p.

    Research output: Contribution to journalArticlepeer-review

  49. Published

    The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

    Daniel Rea, 1 Jan 2015, In: Clinical Oncology. 27, 1, p. 6-8

    Research output: Contribution to journalEditorialpeer-review

  50. E-pub ahead of print

    Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

    & 2 others, Daniel Rea & , Dec 2021, In: Breast Cancer. 7, 1, 8 p., 74.

    Research output: Contribution to journalArticlepeer-review

  51. Published

    Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer

    Daniel Rea, 1 Jan 2004, In: Therapy. 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

  52. Published

    Pathway-based subnetworks enable cross-disease biomarker discovery

    Daniel Rea & 5 others, , , , & , 12 Nov 2018, In: Nature Communications. 9, 1, 4746.

    Research output: Contribution to journalArticlepeer-review

  53. Published

    Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial

    Daniel Rea, , , , , & , Dec 2017, In: Value in Health. 20, 10, p. 1311-1318 8 p.

    Research output: Contribution to journalArticlepeer-review

  54. Published
  55. Published

    Endocrine therapy for early breast cancer

    Syed Hussain, , & Daniel Rea, 1 Oct 2004, In: Expert Review of Anticancer Therapy. 4, p. 877-888 12 p.

    Research output: Contribution to journalArticle

  56. Published
  57. Published

    Role of chemotherapy in breast cancer

    Syed Hussain, Daniel Palmer, , , Christopher Poole & Daniel Rea, 1 Jan 2005, In: Expert Review of Anticancer Therapy. 5, p. 1095-1110 16 p.

    Research output: Contribution to journalArticle

  58. Published

    Molecularly targeted therapeutics for breast cancer

    Syed Hussain, Daniel Palmer, & Daniel Rea, 1 Jan 2007, In: BioDrugs. 21, 4, p. 215-224 10 p.

    Research output: Contribution to journalArticle

  59. Published
  60. Published
  61. Published
  62. Published
  63. Published

    Cardiac safety of simultaneous anti-HER2 and anthracycline therapy

    Mariam Jafri & Daniel Rea, Feb 2016, In: Breast Cancer Management. 5, 1, p. 21-29

    Research output: Contribution to journalArticlepeer-review

  64. Published
  65. Published
  66. Published
  67. Published

    Dietary phytoestrogens influence susceptibility to breast cancer by inhibiting sulphotransferase enzymes?

    Chris Kirk, , , Philip Hughes, , Daniel Rea & Rosemary Waring, 1 Jan 2001, p. 82. 1 p.

    Research output: Contribution to conference (unpublished)Paper

  68. Published
  69. E-pub ahead of print
  70. E-pub ahead of print

    Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

    Daniel Rea, , , , , , , , & , 24 Jul 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO1902427

    Research output: Contribution to journalArticlepeer-review

  71. Published

    Genomics and pharmacogenomics in the management of breast cancer

    Jennifer Pascoe, Daniel Palmer, , Daniel Rea & Syed Hussain, 1 Mar 2009, In: Current Pharmacogenomics. 6, 1, p. 45-55 11 p.

    Research output: Contribution to journalArticle

  72. Published

    The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA.32

    Daniel Rea & 5 others, , , , & , Feb 2021, In: Journal of the National Cancer Institute. 113, 2, p. 192-198 7 p.

    Research output: Contribution to journalArticlepeer-review

  73. Published
  74. Published
  75. Published

    Oncology Emergencies

    Daniel Rea, Stephen Bain & Janesh Gupta, 1 Jan 2006, Core Clinical Cases.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  76. Published

    Time to stop operating on breast cancer patients with pathological complete response?

    Daniel Rea, & , 1 Sep 2013, In: European Journal of Surgical Oncology. 39, 9, p. 924-930 7 p.

    Research output: Contribution to journalReview articlepeer-review

  77. Published

    Chemotherapy for epithelial ovarian cancer: An update

    Daniel Rea & Christopher Poole, 1 Jan 1997, In: Current Obstetrics and Gynaecology. 7, 1, p. 50-60 11 p.

    Research output: Contribution to journalReview articlepeer-review

  78. Published

    Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

    Richard Gray & , 3 Oct 2015, In: The Lancet. 386, 10001, p. 1341-1352 12 p.

    Research output: Contribution to journalArticlepeer-review

  79. Published

    Breast screening saves lives: Now is the time to address overtreatment

    Daniel Rea & , 2014, In: Journal of Comparative Effectiveness Research. 3, 2, p. 111-113 3 p.

    Research output: Contribution to journalEditorialpeer-review

  80. Published
  81. Published
  82. Published

    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first line therapy for advanced colorectal cancer

    Daniel Rea, , , , , , , , , Neil Steven, , & , 25 May 2005, In: Annals of Oncology. 16, 7, p. 1123-1132 10 p.

    Research output: Contribution to journalArticle

  83. Published
  84. Published

    Adjuvant tamoxifen: How long before we know how long?

    Daniel Rea, Christopher Poole & Richard Gray, 16 May 1998, In: BMJ. 316, 7143, 1 p.

    Research output: Contribution to journalArticlepeer-review

  85. Published

    Acute non-myelosuppressive complications of systemic anticancer therapy

    Daniel Rea, 1 Aug 2008, In: Clinical Medicine. 8, 4, p. 439-442 4 p.

    Research output: Contribution to journalEditorial

  86. Published

    From basic science to clinical practice: innovations in cancer therapy.

    Daniel Rea, 1 Dec 1998, In: Hospital medicine (London, England : 1998). 59, 12, p. 918-919 2 p.

    Research output: Contribution to journalEditorialpeer-review

  87. Published
  88. Published

    Recent advances in chemotherapy for colorectal cancer

    Daniel Rea & David Kerr, 1 Jan 2002, In: Cancer Topics. 10, p. 16-19 4 p.

    Research output: Contribution to journalArticle

  89. Published
  90. Published
  91. E-pub ahead of print
  92. Published
  93. Published

    Monitoring the introduction of new drugs: Herceptin and cardiotoxicity

    Daniel Rea & , 1 Jan 2006, In: Clinical Medicine. 6, p. 478-481 4 p.

    Research output: Contribution to journalArticle

  94. Published
  95. Published

    Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

    Daniel Rea & , 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958

    Research output: Contribution to journalArticlepeer-review

  96. Published

    Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

    Daniel Rea, , , , , , , , , , , , , , & , 1 Jun 2009, In: International Journal of Oncology. 34, 6, p. 1629-36 8 p.

    Research output: Contribution to journalArticlepeer-review

  97. Published

    Neoadjuvant chemotherapy in triple negative breast cancer: An observational study

    Daniel Rea, 2 May 2016, In: Oncology Research. 23, 6, p. 291-302 12 p.

    Research output: Contribution to journalArticlepeer-review

  98. Published

    Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

    Toon Brookes, Daniel Rea, , , , , & , 9 Dec 2014, In: British Journal of Cancer. 111, 12, p. 2242-2247 6 p.

    Research output: Contribution to journalArticlepeer-review

  99. E-pub ahead of print

    Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

    Daniel Rea & 1 others, , 26 May 2017, (E-pub ahead of print) In: Modern Pathology. 30, p. 1069-1077

    Research output: Contribution to journalArticlepeer-review

  100. Published

    Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

    Daniel Rea & 8 others, , , , , , , & , Oct 2020, In: The Lancet Oncology. 21, 10, p. 1296-1308 13 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 Next